RT
Healthcare & Life Sciences
Renova Therapeutics
United Statesrenovatherapeutics.com/about/overview
Renova Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 1 tracked investor.
series-c-plus
series-c-plus
Stage
1
Investors
About Renova Therapeutics
Based in the United States, Renova Therapeutics is a startup. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Renova Therapeutics develops gene therapies aimed at treating chronic cardiovascular and metabolic diseases, including congestive heart failure and type 2 diabetes, by leveraging proprietary gene therapy platforms.
Explore Renova Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.